← HUTCHMED (China) Ltd HCM
Market Price
$12.19
Market Cap
$2.11B
P/E Ratio
23.44
Revenue (FY 2025)
↓-13.0% YoY
$548.51M
3-Yr CAGR: 8.8%
Net Income
↑1,111.0% YoY
$456.91M
Net Margin: 83.3%
Free Cash Flow
↓-352.0% YoY
-$78.81M
FCF Yield: -3.73%
EPS (Diluted)
↑1,200.0% YoY
$0.52
Basic: $0.53
Return on Equity
Efficiency
36.9%
ROA: 29.2%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (HCM)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $216.1M | — | $66.9M | $11.7M | — | $0.20 | — | $-9.6M | $-13.9M | — |
| FY 2017 | $241.2M | +11.6% | $71.4M | $-26.7M | -328.6% | $-0.43 | -315.0% | $-8.9M | $-14.0M | -0.5% |
| FY 2018 | $214.1M | -11.2% | $198.5M | $-74.8M | -179.8% | $-1.13 | -162.8% | $-32.8M | $-39.2M | -180.8% |
| FY 2019 | $204.9M | -4.3% | $191.5M | $-106.0M | -41.7% | — | — | $-80.9M | $-89.5M | -128.2% |
| FY 2020 | $228.0M | +11.3% | $214.0M | $-125.7M | -18.6% | — | — | $-62.1M | $-70.0M | +21.8% |
| FY 2021 | $356.1M | +56.2% | $345.5M | $-194.6M | -54.8% | $-0.25 | — | $-204.2M | $-220.6M | -215.1% |
| FY 2022 | $426.4M | +19.7% | $418.5M | $-360.8M | -85.4% | $-0.43 | -72.0% | $-268.6M | $-305.3M | -38.4% |
| FY 2023 | $838.0M | +96.5% | $832.3M | $100.8M | +127.9% | $0.12 | +127.9% | $219.3M | $186.6M | +161.1% |
| FY 2024 | $630.2M | -24.8% | $281.3M | $37.7M | -62.6% | $0.04 | -66.7% | $0.5M | $-17.4M | -109.3% |
| FY 2025 | $548.5M | -13.0% | $212.2M | $456.9M | +1,111.0% | $0.52 | +1,200.0% | $-64.7M | $-78.8M | -352.0% |
Valuation
Market Price
$12.19
Market Cap
$2.11B
Enterprise Value
$2.14B
P/E Ratio
23.44
P/B Ratio
1.71
FCF Yield
-3.73%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
38.68%
Operating Margin
7.14%
Net Margin
83.30%
Return on Equity (ROE)
36.91%
Return on Assets (ROA)
29.15%
Asset Turnover
0.35x
Revenue 3-Yr CAGR
8.76%
Financial Health & Liquidity
Current Ratio
4.96
Cash Ratio
0.23
Debt / Equity
0.075
Debt / Assets
0.059
Cash & Equivalents
$71.33M
Total Debt
$93.16M
Book Value / Share
$7.12
Cash Flow Efficiency
Operating Cash Flow
-$64.66M
Capital Expenditures (CapEx)
$14.15M
Free Cash Flow
-$78.81M
OCF / Revenue
-11.79%
FCF / Revenue
-14.37%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$0.52
EPS (Basic)
$0.53
Dividends / Share
N/A
Book Value / Share
$7.12
EPS YoY Growth
1,200.00%
Balance Sheet (FY 2025)
Total Assets
$1.57B
Total Liabilities
$315.77M
Stockholders' Equity
$1.24B
Current Assets
$1.57B
Current Liabilities
$315.77M